Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Aldeyra Therapeutics, Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES
Ticker
Exchange
SIC #
Website
Latest Ticker
ALDX
Nasdaq
2836
www.aldeyra.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Aldeyra Therapeutics, Inc.
Wall Street Analysts Predict a 65.75% Upside in Aldeyra Therapeutics (ALDX): Here's What You Should Know
- Feb 3rd, 2026 7:55 am
Are Medical Stocks Lagging Aldeyra Therapeutics (ALDX) This Year?
- Feb 3rd, 2026 7:40 am
ATA Creativity Global Among 3 Promising Penny Stocks
- Jan 20th, 2026 5:05 am
Aldeyra Therapeutics And 2 Other Promising Penny Stocks For Your Watchlist
- Dec 22nd, 2025 5:05 am
Aldeyra Says FDA Extends Action Date for Potential Dry Eye Disease Treatment; Shares Down Pre-Bell
- Dec 16th, 2025 4:10 am
Aldeyra Therapeutics Announces PDUFA Extension of the New Drug Application of Reproxalap for the Treatment of Dry Eye Disease
- Dec 15th, 2025 5:30 pm
Aldeyra Therapeutics, Inc.'s (NASDAQ:ALDX) recent 10% pullback adds to one-year year losses, institutional owners may take drastic measures
- Dec 8th, 2025 3:49 am
Inherited Retinal Disease Market Analysis Report 2025-2035, Featuring Profiles of Novartis, GenSight Biologics, Aldeyra Therapeutics, and Spark Therapeutics
- Nov 19th, 2025 7:05 am
Aldeyra Therapeutics Announces Expansion of RASP Platform to Include Central Nervous System Diseases and Provides Updates on Reproxalap at Research & Development Webcast
- Nov 13th, 2025 5:00 am
Aldeyra Therapeutics to Participate in the Jefferies Global Healthcare Conference in London
- Nov 11th, 2025 5:01 am
High Growth Tech Stocks In The US Market November 2025
- Nov 6th, 2025 10:38 am
Aldeyra Therapeutics to Host Research & Development Update Webcast Event Scheduled for Thursday, November 13 at 8:00 a.m. ET
- Nov 6th, 2025 5:00 am
Exploring 3 High Growth Tech Stocks In The US Market
- Nov 6th, 2025 4:38 am
High Growth Tech Opportunities in the US Market
- Nov 5th, 2025 4:38 am
High Growth Tech Stocks In US With Promising Potential
- Oct 31st, 2025 11:38 am
High Growth Tech Stocks In The US Market With Promising Potential
- Oct 31st, 2025 5:38 am
High Growth Tech Stocks To Watch In US This October 2025
- Oct 30th, 2025 5:38 am
Aldeyra reshuffles pipeline, culling asset despite Phase II success
- Oct 29th, 2025 6:16 am
High Growth Tech Stocks in the US Market
- Oct 29th, 2025 5:38 am
US High Growth Tech Stocks To Watch Now
- Oct 28th, 2025 5:38 am
Scroll